ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1593

Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis

Michelle J. Ormseth1, Joseph F. Solus2, Annette M. Oeser3, Aihua Bian4, Tebeb Gebretsadik4, Ayumi Shintani5, Paolo Raggi6 and C Michael Stein5, 1Department of Medicine, Division of Rheumatology, Vanderbilt University, Nashville, TN, 2Clinical Pharmacology, Vanderbilt University, Nashville, TN, 3Medicine, Vanderbilt University, Nashville, TN, 4Biostatistics, Vanderbilt University, Nashville, TN, 5Vanderbilt University, Nashville, TN, 6Emory University, Atlanta, GA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Aging, Atherosclerosis, Cardiovascular disease and rheumatoid arthritis (RA), Telomeres

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Telomeres protect against DNA damage and
shorten with each cell division; their length may be a marker of cardiovascular
and overall biological aging. Patients with rheumatoid arthritis (RA) have
accelerated cardiovascular disease resulting in early mortality. The
relationship between telomere length and atherosclerosis in RA is not known. We
examined the hypothesis that reduced telomere length is associated with
increased coronary atherosclerosis in RA.

Methods: We performed a cross-sectional study in 145 patients with
RA and 87 control subjects frequency matched
for age, race and sex. Coronary artery calcium score, a measure of coronary
atherosclerosis, was determined by non-contrast cardiac computed tomography.
Telomere length was measured from DNA extracted from whole blood, using
real-time quantitative polymerase chain reaction and expressed as the ratio of telomeric repeats to a single-copy gene (T/S ratio). The
associations between telomere length and coronary artery calcium score and
disease activity (DAS28) were assessed with Spearman correlation, proportional
odds logistic regression, and linear regression adjusting for age, race and sex
in patients with RA.

Results: Telomere length was significantly inversely correlated with
age in patients with RA (rho=-0.37, P<0.001) and control subjects
(rho=-0.39, P=0.001). Among patients with RA, for every interquartile range
(IQR) decrease in telomere length (T/S ratio), the odds of higher coronary
artery calcium score increased by 38% (95% CI: 4, 60%), after adjusting for
age, race and sex (P adjusted= 0.03) (Figure). 
Telomere length was not associated with DAS28 (P adjusted= 0.17).
Telomere length was not significantly different in patients with RA (median
[IQR]: 1.02 units [0.9, 1.11 units]) compared to control subjects (1.05 units
[0.95, 1.17 units]; P= 0.10).

Conclusion: Telomere length is inversely associated with coronary
artery calcium score independent of age, race and sex in patients with RA.


Disclosure: M. J. Ormseth, None; J. F. Solus, None; A. M. Oeser, None; A. Bian, None; T. Gebretsadik, None; A. Shintani, None; P. Raggi, None; C. M. Stein, None.

To cite this abstract in AMA style:

Ormseth MJ, Solus JF, Oeser AM, Bian A, Gebretsadik T, Shintani A, Raggi P, Stein CM. Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/telomere-length-and-cardiovascular-risk-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/telomere-length-and-cardiovascular-risk-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology